Nivolumab,Ipilimumab,Tocilizumab
Roche,BMS
['ease,(-please),(-disease),(-incrrease),(-decrease)', 'nivo', 'nivolumab', 'ipilimumab']
abdel-wahab et al. tcz in combo with ipilimumab/nivolumab. very preliminary results of what will be important trial. appears safe and well-tolerated with no increased risk cancer progression. #acr22 abstr#1670 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC